Development of a biochip-based assay integrated in a global strategy for identification of fusion transcripts in acute myeloid leukemia: A work flow for acute myeloid leukemia diagnosis

International Journal of Laboratory Hematology

Volumn 32, Issue 4, 2010, Pages 398-409

  Giusiano, S ^a   Formisano Treziny, C ^b   Benziane, A ^c   Maroc, N ^c   Picard, C ^d   Hermitte, F ^c   Taranger Charpin, C ^a   Gabert, J ^a,b  

^a HÔPITAL NORD   (France)

^b University of the Mediterranean Aix Marseille II   (France)

^c Ipsogen SA   (France)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Acute myeloid leukemia; Biochip; Fusion transcript; Minimal residual disease monitoring; Real time quantitative polymerase chain reaction

Indexed keywords

AMSACRINE; CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BIOCHIP; CASE REPORT; CELL LINE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE FUSION; GENE IDENTIFICATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 77957938054     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2009.01201.x     Document Type: Article

References (45)

1. Beillard E., Pallisgaard N., van der Velden V. H., Bi W., Dee R., van der Schoot E., Delabesse E., Macintyre E., Gottardi E., Saglio G., Watzinger F., Lion T., van Dongen J. J., Hokland P. & Gabert J. (2003) Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia 17, 2474-2486.
2. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R. & Sultan C. (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. British Journal of Haematology 33, 451-458.
3. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R. & Sultan C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American- British Cooperative Group. Annals of Internal Medicine 103, 620-625.
4. Bloomfield C. D., Lawrence D., Byrd J. C., Carroll A., Pettenati M. J., Tantravahi R., Patil S. R., Davey F. R., Berg D. T., Schiffer C. A., Arthur D. C. & Mayer R. J. (1998) Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Research 58, 4173-4179.
5. Braess J., Jahns-Streubel G., Schoch C., Haase D., Haferlach T., Fiegl M., Voss S., Kern W., Schleyer E. & Hiddemann W. (2001) Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroups in acute myeloid leukaemia. British Journal of Haematology 113, 975-982.
6. Corral J., Forster A., Thompson S., Lampert F., Kaneko Y., Slater R., Kroes W. G., van der Schoot C. E., Ludwig W. D. & Karpas A. (1993) Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proceedings of the National Academy of Sciences of the United States of America 90, 8538-8542.
7. Costello R., Sainty D., Lecine P., Cusenier A., Mozziconacci M. J., Arnoulet C., Maraninchi D., Gastaut J. A., Imbert J., Lafage-Pochitaloff M. & Gabert J. (1997) Detection of CBFbeta/MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristics. Leukemia 11, 644-650.
8. van Dongen J. J., Macintyre E. A., Gabert J. A., Delabesse E., Rossi V., Saglio G., Gottardi E., Rambaldi A., Dotti G., Griesinger F., Parreira A., Gameiro P., Diaz M. G., Malec M., Langerak A. W., San Miguel J. F. & Biondi A. (1999) Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 13, 1901-1928.
9. Felix C. A. & Jones D. H. (1998) Panhandle PCR: a technical advance to amplify MLL genomic translocation breakpoints. Leukemia 12, 976-981.
10. Felix C. A., Kim C. S., Megonigal M. D., Slater D. J., Jones D. H., Spinner N. B., Stump T., Hosler M. R., Nowell P. C., Lange B. J. & Rappaport E. F. (1997) Panhandle polymerase chain reaction amplifies MLL genomic translocation breakpoint involving unknown partner gene. Blood 90, 4679-4686.
11. Gabert J., Beillard E., van der Velden V. H., Bi W., Grimwade D., Pallisgaard N., Barbany G., Cazzaniga G., Cayuela J. M., Cave H., Pane F., Aerts J. L., De Micheli D., Thirion X., Pradel V., Gonzalez M., Viehmann S., Malec M., Saglio G. & van Dongen J. J. (2003) Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 17, 2318-2357.
12. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., Rees J., Hann I., Stevens R., Burnett A. & Goldstone A. (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1, 612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92, 2322-2333.
13. Haferlach T., Schnittger S., Kern W., Hiddemann W. & Schoch C. (2004) Genetic classification of acute myeloid leukemia (AML). Annals of Hematology 83 (Suppl. 1), S97-S100.
14. Hiddemann W., Haferlach T., Schoch C., Behre G., Kohlmann A., Kern W., Feuring-Buske M. & Bohlander S. (2003) New insights into the biology of acute myeloid leukemia and their impact on treatment. Verhandlungen der Deutschen Gesellschaft fur Pathologie 87, 72-78.
15. Ishii E., Kawasaki H., Isoyama K., Eguchi-Ishimae M. & Eguchi M. (2003) Recent advances in the treatment of infant acute myeloid leukemia. Leukemia & Lymphoma 44, 741-748.
16. Kadkol S. S., Bruno A., Dodge C., Lindgren V. & Ravandi F. (2004) Comprehensive analysis of CBFbeta-MYH11 fusion transcripts in acute myeloid leukemia by RT-PCR analysis. Journal of Molecular Diagnosis 6, 22-27.
17. Klaus M., Haferlach T., Schnittger S., Kern W., Hiddemann W. & Schoch C. (2004) Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization. Cancer Genetics and Cytogenetics 155, 47-56.
18. Maroc N., Morel A., Beillard E., De La Chapelle A. L., Fund X., Mozziconacci M. J., Dupont M., Cayuela J. M., Gabert J., Koki A., Fert V. & Hermitte F. (2004) A diagnostic biochip for the comprehensive analysis of MLL translocations in acute leukemia. Leukemia 18, 1522-1530.
19. Martinez-Climent J. A., Espinosa R., III, Thirman M. J., Le Beau M. M. & Rowley J. D. (1995) Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias. Identification of the t (9;11) as an indicator of long survival. Journal of Pediatric Hematology and Oncology 17, 277-283.
20. Megonigal M. D., Rappaport E. F., Jones D. H., Kim C. S., Nowell P. C., Lange B. J. & Felix C. A. (1997) Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias. Proceedings of the National Academy of Sciences of the United States of America 94, 11583-11588.
21. Megonigal M. D., Rappaport E. F., Wilson R. B., Jones D. H., Whitlock J. A., Ortega J. A., Slater D. J., Nowell P. C. & Felix C. A. (2000) Panhandle PCR for cDNA: a rapid method for isolation of MLL fusion transcripts involving unknown partner genes. Proceedings of the National Academy of Sciences of the United States of America 97, 9597-9602.
22. Meyer C., Schneider B., Reichel M., Angermueller S., Strehl S., Schnittger S., Schoch C., Jansen M. W., van Dongen J. J., Pieters R., Haas O. A., Dingermann T., Klingebiel T. & Marschalek R. (2005) Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Proceedings of the National Academy of Sciences of the United States of America 102, 449-454.
23. Meyer C., Kowarz E., Schneider B., Oehm C., Klingebiel T., Dingermann T. & Marschalek R. (2006) Genomic DNA of leukemic patients: target for clinical diagnosis of MLL rearrangements. Biotechnology Journal 1, 656-663.
24. Meyer C., Kowarz E., Hofmann J., Renneville A., Zuna J., Trka J., Ben Abdelali R., Macintyre E., De Braekeleer E., De Braekeleer M., Delabesse E., de Oliveira M. P., Cave H., Clappier E., van Dongen J. J., Balgobind B. V., van den Heuvel-Eibrink M. M., Beverloo H. B., Panzer-Grumayer R., Teigler-Schlegel A., Harbott J., Kjeldsen E., Schnittger S., Koehl U., Gruhn B., Heidenreich O., Chan L. C., Yip S. F., Krzywinski M., Eckert C., Moricke A., Schrappe M., Alonso C. N., Schafer B. W., Krauter J., Lee D. A., Zur Stadt U., Te Kronnie G., Sutton R., Izraeli S., Trakhtenbrot L., Lo Nigro L., Tsaur G., Fechina L., Szczepanski T., Strehl S., Ilencikova D., Molkentin M., Burmeister T., Dingermann T., Klingebiel T. & Marschalek R. (2009) New insights to the MLL recombinome of acute leukemias. Leukemia 23, 1490-1499.
25. Mitterbauer M., Laczika K., Novak M., Mitterbauer G., Hilgarth B., Pirc-Danoewinata H., Schwarzinger I., Haas O. A., Fonatsch C., Lechner K. & Jaeger U. (2000) High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia. A single center study. American Journal of Clinical Pathology 113, 406-410.
26. Monma F., Nishii K., Shiga J., Sugahara H., Lorenzo F.t., Watanabe Y., Kawakami K., Hosokai N., Yamamori S., Katayama N. & Shiku H. (2007) Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): a single-institution study of 224 Japanese AML patients. Leukemia Research 31, 471-476.
27. Nam D. K., Honoki K., Yu M. & Yunis J. J. (1996) Alternative RNA splicing of the MLL gene in normal and malignant cells. Gene 178, 169-175.
28. Nasedkina T., Domer P., Zharinov V., Hoberg J., Lysov Y. & Mirzabekov A. (2002) Identification of chromosomal translocations in leukemias by hybridization with oligonucleotide microarrays. Haematologica 87, 363-372.
29. Nasedkina T. V., Zharinov V. S., Isaeva E. A., Mityaeva O. N., Yurasov R. N., Surzhikov S. A., Turigin A. Y., Rubina A. Y., Karachunskii A. I., Gartenhaus R. B. & Mirzabekov A. D. (2003) Clinical screening of gene rearrangements in childhood leukemia by using a multiplex polymerase chain reaction-microarray approach. Clinical Cancer Research 9, 5620-5629.
30. Nilson I., Lochner K., Siegler G., Greil J., Beck J. D., Fey G. H. & Marschalek R. (1996) Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias. British Journal of Haematology 93, 966-972.
31. van der Reijden B. A., Lombardo M., Dauwerse H. G., Giles R. H., Muhlematter D., Bellomo M. J., Wessels H. W., Beverstock G. C., van Ommen G. J. & Hagemeijer A. (1995) RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv (16) (p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts. Blood 86, 277-282.
32. Rowley J. D. (2008) Chromosomal translocations: revisited yet again. Blood 112, 2183-2189.
33. Sanz M. A. (2006) Treatment of acute promyelocytic leukemia. Hematology American Society of Hematology Education Program 147-155.
34. Schichman S. A., Caligiuri M. A., Strout M. P., Carter S. L., Gu Y., Canaani E., Bloomfield C. D. & Croce C. M. (1994) ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Research 54, 4277-4280.
35. Schoch C., Schnittger S., Klaus M., Kern W., Hiddemann W. & Haferlach T. (2003) AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 102, 2395-2402.
36. Shi R. Z., Morrissey J. M. & Rowley J. D. (2003) Screening and quantification of multiple chromosome translocations in human leukemia. Clinical Chemistry 49, 1066-1073.
37. Shih L. Y., Liang D. C., Fu J. F., Wu J. H., Wang P. N., Lin T. L., Dunn P., Kuo M. C., Tang T. C., Lin T. H. & Lai C. L. (2006) Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement. Leukemia 20, 218-223.
38. Shurtleff S. A., Meyers S., Hiebert S. W., Raimondi S. C., Head D. R., Willman C. L., Wolman S., Slovak M. L., Carroll A. J. & Behm F. (1995) Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv (16) (p13q22) and the t (16;16) (p13;q22) in acute myelogenous leukemia. Blood 85, 3695-3703.
39. Stulberg J., Kamel-Reid S., Chun K., Tokunaga J. & Wells R. A. (2002) Molecular analysis of a new variant of the CBF beta-MYH11 gene fusion. Leukemia & Lymphoma 43, 2021-2026.
40. Taki T., Akiyama M., Saito S., Ono R., Taniwaki M., Kato Y., Yuza Y., Eto Y. & Hayashi Y. (2005) The MYO1F, unconventional myosin type 1F, gene is fused to MLL in infant acute monocytic leukemia with a complex translocation involving chromosomes 7, 11, 19 and 22. Oncogene 24, 5191-5197.
41. Tighe J. E. & Calabi F. (1994) Alternative, out-of-frame runt/MTG8 transcripts are encoded by the derivative (8) chromosome in the t (8;21) of acute myeloid leukemia M2. Blood 84, 2115-2121.
42. Vey N., Mozziconacci M. J., Groulet-Martinec A., Debono S., Finetti P., Carbuccia N., Beillard E., Devilard E., Arnoulet C., Coso D., Sainty D., Xerri L., Stoppa A. M., Lafage-Pochitaloff M., Nguyen C., Houlgatte R., Blaise D., Maraninchi D., Birg F., Birnbaum D. & Bertucci F. (2004) Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling. Oncogene 23, 9381-9391.
43. Weisser M., Haferlach C., Hiddemann W. & Schnittger S. (2007) The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factors. Leukemia 21, 1177-1182.
44. Yamamoto K., Seto M., Komatsu H., Iida S., Akao Y., Kojima S., Kodera Y., Nakazawa S., Ariyoshi Y. & Takahashi T. (1993) Two distinct portions of LTG19/ENL at 19p13 are involved in t (11;19) leukemia. Oncogene 8, 2617-2625.
45. Yu M., Honoki K., Andersen J., Paietta E., Nam D. K. & Yunis J. J. (1996) MLL tandem duplication and multiple splicing in adult acute myeloid leukemia with normal karyotype. Leukemia 10, 774-780.